477 related articles for article (PubMed ID: 26169263)
1. Estimation of the benchmark dose of urinary cadmium as the reference level for renal dysfunction: a large sample study in five cadmium polluted areas in China.
Ke S; Cheng XY; Zhang JY; Jia WJ; Li H; Luo HF; Ge PH; Liu ZM; Wang HM; He JS; Chen ZN
BMC Public Health; 2015 Jul; 15():656. PubMed ID: 26169263
[TBL] [Abstract][Full Text] [Related]
2. Application of the Benchmark Dose (BMD) Method to Identify Thresholds of Cadmium-Induced Renal Effects in Non-Polluted Areas in China.
Wang X; Wang Y; Feng L; Tong Y; Chen Z; Ying S; Chen T; Li T; Xia H; Jiang Z; Shang Q; Lou X; Lou J
PLoS One; 2016; 11(8):e0161240. PubMed ID: 27537182
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment for Thai population: benchmark dose of urinary and blood cadmium levels for renal effects by hybrid approach of inhabitants living in polluted and non-polluted areas in Thailand.
Nishijo M; Suwazono Y; Ruangyuttikarn W; Nambunmee K; Swaddiwudhipong W; Nogawa K; Nakagawa H
BMC Public Health; 2014 Jul; 14():702. PubMed ID: 25012790
[TBL] [Abstract][Full Text] [Related]
4. Benchmark Dose Estimation for Cadmium-Induced Renal Effects Based on a Large Sample Population from Five Chinese Provinces.
Ke S; Ke QM; Jia WJ; Cheng XY; Li H; Zhang JY; Luo HF; He JS; Chen ZN
Biomed Environ Sci; 2015 May; 28(5):383-7. PubMed ID: 26055567
[TBL] [Abstract][Full Text] [Related]
5. An assessment of sensitivity biomarkers for urinary cadmium burden.
Li Y; Wang H; Yu J; Yan Q; Hu H; Zhang L; Tian T; Peng X; Yang S; Ke S
BMC Nephrol; 2020 Sep; 21(1):385. PubMed ID: 32891117
[TBL] [Abstract][Full Text] [Related]
6. [Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method].
Hong F; Jin TY; Zhang AH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):374-8. PubMed ID: 15569507
[TBL] [Abstract][Full Text] [Related]
7. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.
Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
Environ Res; 2006 Jul; 101(3):401-6. PubMed ID: 16436274
[TBL] [Abstract][Full Text] [Related]
8. Estimation of benchmark dose for renal dysfunction in a cadmium non-polluted area in Japan.
Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
J Appl Toxicol; 2006; 26(4):351-5. PubMed ID: 16791912
[TBL] [Abstract][Full Text] [Related]
9. Application of BMD approach to identify thresholds of cadmium-induced renal effect among 35 to 55 year-old women in two cadmium polluted counties in China.
Wang Q; Hu J; Han TX; Li M; Zhao HH; Chen JW; Ye LX; Zhou YK
PLoS One; 2014; 9(2):e87817. PubMed ID: 24505316
[TBL] [Abstract][Full Text] [Related]
10. Estimation of benchmark doses as threshold levels of urinary cadmium, based on excretion of beta2-microglobulin in cadmium-polluted and non-polluted regions in Japan.
Kobayashi E; Suwazono Y; Dochi M; Honda R; Nishijo M; Kido T; Nakagawa H
Toxicol Lett; 2008 Jun; 179(2):108-12. PubMed ID: 18515022
[TBL] [Abstract][Full Text] [Related]
11. Body burden of cadmium and its related factors: a large-scale survey in China.
Ke S; Cheng XY; Li H; Jia WJ; Zhang JY; Luo HF; Wang ZL; Chen ZN
Sci Total Environ; 2015 Apr; 511():649-54. PubMed ID: 25594907
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of the threshold of urinary cadmium by using hybrid approach in a cadmium non-polluted area in Japan.
Suwazono Y; Nogawa K; Uetani M; Kido T; Nakagawa H
Int J Hyg Environ Health; 2011 Mar; 214(2):175-8. PubMed ID: 20889376
[TBL] [Abstract][Full Text] [Related]
13. [Cadmium burden and renal dysfunction among residents in cadmium-polluted areas: A 3-year follow-up study].
Li ZX; Wang P; Huang R; Liang XX; Dun ZJ; Jiang Q; Huang Q; Ling HT; Wang J; Tan JB; Wu SX; Chen ZH; Gao YY; Lyu YJ; Wu YN; Yang XF
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):322-7. PubMed ID: 27029363
[TBL] [Abstract][Full Text] [Related]
14. Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China.
Jin T; Wu X; Tang Y; Nordberg M; Bernard A; Ye T; Kong Q; Lundström NG; Nordberg GF
Biometals; 2004 Oct; 17(5):525-30. PubMed ID: 15688857
[TBL] [Abstract][Full Text] [Related]
15. Variation in benchmark dose (BMD) and the 95% lower confidence limit of benchmark dose (BMDL) among general Japanese populations with no anthropogenic exposure to cadmium.
Sakuragi S; Takahashi K; Hoshuyama T; Moriguchi J; Ohashi F; Fukui Y; Ikeda M
Int Arch Occup Environ Health; 2012 Nov; 85(8):941-50. PubMed ID: 22270387
[TBL] [Abstract][Full Text] [Related]
16. Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters.
Lei LJ; Chen L; Jin TY; Nordberg M; Chang XL
Toxicol Sci; 2007 May; 97(1):189-95. PubMed ID: 17303580
[TBL] [Abstract][Full Text] [Related]
17. Estimation of benchmark doses for urinary cadmium based on beta2-microglobulin excretion in cadmium-polluted regions of the Kakehashi River basin, Japan.
Shimizu A; Kobayashi E; Suwazono Y; Uetani M; Oishi M; Inaba T; Kido T; Nogawa K
Int J Environ Health Res; 2006 Oct; 16(5):329-37. PubMed ID: 16990174
[TBL] [Abstract][Full Text] [Related]
18. Benchmark dose estimation for cadmium-induced renal tubular damage among environmental cadmium-exposed women aged 35-54 years in two counties of China.
Hu J; Li M; Han TX; Chen JW; Ye LX; Wang Q; Zhou YK
PLoS One; 2014; 9(12):e115794. PubMed ID: 25536107
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population.
Hong F; Jin T; Zhang A
Biometals; 2004 Oct; 17(5):573-80. PubMed ID: 15688868
[TBL] [Abstract][Full Text] [Related]
20. [Application of benchmark dose (BMD) in a bone-effect study on a general population environmentally exposed to cadmium].
Qian HL; Jin TY; Kong QH; Wang HF; Zhu GY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):23-6. PubMed ID: 16600089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
